Intuitive Surgical Stock News

Baron Fifth Avenue Growth Fund gained 5.7% during the third quarter, lagging the 10.5% gain for the Russell 1000 Growth Index and the 8.1% gain for the S&P 500 Index, the Fund's benchmarks. NVIDIA reported mid-term visibility of tens of GWs in AI buildouts, with each GW representing an estimated $35 billion total addressable market. Growth was broad-based across Shopify's core e-commerce mercha...

Intuitive Surgical makes da Vinci surgical robots used around the globe. The company has seen tremendous growth and is still growing quickly.

These companies are leaders in their respective industries and are both very profitable. Intuitive Surgical has been the dominant presence in the surgical robotics market for decades.

Intuitive Surgical reduced its projected tariff impact on gross margins by 30 basis points this quarter. The medical device leader's ability to navigate tariff uncertainty while raising guidance across the board highlights the lasting benefits of protecting margins at the top of the income statement.

GOOG was our top contributor in the quarter, benefiting from accelerating momentum in its core Search and YouTube franchises. We continue to view Alphabet as among the best-positioned secular growth franchises in the market. NVDA shares advanced during the quarter after once again reporting blowout results that exceeded even elevated expectations.

When it comes to surgical innovation, Intuitive Surgical (NASDAQ: ISRG) often dominates investor attention. But Insulet Corporation (NASDAQ: PODD), best known for its Omnipod insulin delivery system, is emerging as a compelling alternative in the health care equipment space.

Intuitive Surgical features in Ark Invest and Millennium Management's portfolios. The company is facing issues: mounting competition, tariffs, and a steep valuation.

Intuitive Surgical's da Vinci surgical robot is an industry leader in one specific area. Medtronic offers both a surgical robot and a more diverse business beyond it.